Center for Research in Emerging Infectious Diseases: Studying Tick-Borne and Respiratory Viruses Worldwide
Official title: Center for Research in Emerging Infectious Diseases - Epidemiology, Surveillance and Pathogenesis
Funded at Washington University · NIH-11612507 · Data updated 2026-11-12
Researchers will study how emerging viruses in the Midwest U.S. and in Asia affect people and animals, with a focus on tick-borne and respiratory viruses and how they may spill over to humans.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | May 11, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $266,274 |
| NIH project number | 3U01AI151810-06S3 |
| Project ID | NIH-11612507 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with respiratory illness or fever, and people who have close contact with animals in areas of study, may be eligible or contribute samples.
✕Less likely to help
Healthy individuals without exposure or symptoms are unlikely to benefit directly from this research.
What this research studies
This program looks at viruses found in the Midwest U.S. and in Hong Kong, Nepal, and Korea to understand how they emerge and spread. It will track viruses carried by ticks and animals that come into contact with people, and also examine respiratory viruses that can jump between animals and humans. Scientists will collect samples from ticks, animals, and people with fever or respiratory symptoms to map virus presence and spread. The study combines field surveillance with laboratory analysis to identify high-risk viruses and how they move through ecosystems.
Why it matters
Potential benefit: If successful, the work could improve early warning of dangerous viral outbreaks and inform prevention strategies for people and animals.
How similar studies have gone: Past work has identified emerging pathogens through integrated surveillance and sequencing, supporting the approach as promising but complex.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Wang, David — Washington University
- Study coordinator: Wang, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.